유세포 분석 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is estimated to reach USD 7,013.1 million by 2030, registering to grow at a CAGR of 8.41% from 2025 to 2030 according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

• The instrument segment led the market with the largest revenue share of 35.30% in 2024 with owing to higher penetration driven by technological developments.
• Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024.
• Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024.
• Based on end use, the academic institutes segment accounted for the largest revenue share in 2024, driven by the extensive use of flow cytometry in cell biology and molecular diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Flow Cytometry Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Growing prevalence of chronic and infectious diseases
    • 3.3.1.2. High R&D investments in biotechnology, clinical, and life science research
    • 3.3.1.3. Technological advancements in flow cytometry instruments and reagents
    • 3.3.1.4. Increasing demand for point-of-care diagnostics
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. High cost of instruments
• 3.4. Flow Cytometry Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Flow Cytometry Market: Product Estimates & Trend Analysis

• 4.1. Flow Cytometry Market: Product Movement Analysis
• 4.2. Flow Cytometry Market: Product Movement Analysis, USD Million, 2024 & 2030
• 4.3. Instruments
  • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Cell Analyzers
    • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Cell Sorters
    • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Reagents & Consumables
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Software
  • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Accessories
  • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Flow Cytometry Market: Technology Estimates & Trend Analysis

• 5.1. Flow Cytometry Market: Technology Movement Analysis
• 5.2. Flow Cytometry Market: Technology Movement Analysis, USD Million, 2024 & 2030
• 5.3. Cell-based
  • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Bead-based
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Flow Cytometry Market: Application Estimates & Trend Analysis

• 6.1. Flow Cytometry Market: Application Movement Analysis
• 6.2. Flow Cytometry Market: Application Movement Analysis, USD Million, 2024 & 2030
• 6.3. Research
  • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Pharmaceutical
    • 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.2. Drug Discovery
      • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.3. Drug In Vitro Toxicity
      • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2.4. Drug Stem Cell
      • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Drug Apoptosis
    • 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Cell Sorting
    • 6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Cell Cycle Analysis
    • 6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Immunology
    • 6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Cell Viability
• 6.4. Industrial
  • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Clinical
  • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Cancer
    • 6.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Organ Transplantation
    • 6.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Immunodeficiency
    • 6.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Hematology
    • 6.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Autoimmune Disorders

Chapter 7. Flow Cytometry Market: End Use Estimates & Trend Analysis

• 7.1. Flow Cytometry Market: End Use Movement Analysis
• 7.2. Flow Cytometry Market: End Use Movement Analysis, USD Million, 2024 & 2030
• 7.3. Clinical Testing Labs
  • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Academic Institutes
  • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Commercial Organizations
  • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Biotechnology Companies
    • 7.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Pharmaceutical Companies
    • 7.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. CROs
• 7.6. Hospitals
  • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Flow Cytometry Market: Regional Estimates & Trend Analysis

• 8.1. Flow Cytometry Market Share, By Region, 2024 & 2030, USD Million
• 8.2. North America
  • 8.2.1. North America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2.2. Country Dynamics
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. Regulatory Scenario
  • 8.2.3. Canada
    • 8.2.3.1. Canada Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3.2. Country Dynamics
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Regulatory Scenario
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4.2. Country Dynamics
    • 8.2.4.3. Competitive Scenario
    • 8.2.4.4. Regulatory Scenario
• 8.3. Europe
  • 8.3.1. Europe Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. UK Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2.2. Country Dynamics
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. Regulatory Scenario
  • 8.3.3. Germany
    • 8.3.3.1. Germany Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3.2. Country Dynamics
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Scenario
  • 8.3.4. France
    • 8.3.4.1. France Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4.2. Country Dynamics
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Scenario
  • 8.3.5. Italy
    • 8.3.5.1. Italy Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5.2. Country Dynamics
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Regulatory Scenario
  • 8.3.6. Spain
    • 8.3.6.1. Spain Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6.2. Country Dynamics
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Regulatory Scenario
  • 8.3.7. Denmark
    • 8.3.7.1. Denmark Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7.2. Country Dynamics
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Regulatory Scenario
  • 8.3.8. Sweden
    • 8.3.8.1. Sweden Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8.2. Country Dynamics
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Regulatory Scenario
  • 8.3.9. Norway
    • 8.3.9.1. Norway Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9.2. Country Dynamics
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Regulatory Scenario
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Japan Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2.2. Country Dynamics
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Regulatory Scenario
  • 8.4.3. China
    • 8.4.3.1. China Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3.2. Country Dynamics
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Scenario
  • 8.4.4. India
    • 8.4.4.1. India Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4.2. Country Dynamics
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Scenario
  • 8.4.5. Australia
    • 8.4.5.1. Australia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5.2. Country Dynamics
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Scenario
  • 8.4.6. South Korea
    • 8.4.6.1. South Korea Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6.2. Country Dynamics
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Scenario
  • 8.4.7. Thailand
    • 8.4.7.1. Thailand Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7.2. Country Dynamics
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Scenario
• 8.5. Latin America
  • 8.5.1. Latin America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2.2. Country Dynamics
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Regulatory Scenario
  • 8.5.3. Argentina
    • 8.5.3.1. Argentina Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3.2. Country Dynamics
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Scenario
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2.2. Country Dynamics
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. Regulatory Scenario
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3.2. Country Dynamics
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Scenario
  • 8.6.4. UAE
    • 8.6.4.1. UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4.2. Country Dynamics
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Regulatory Scenario
  • 8.6.5. Kuwait
    • 8.6.5.1. Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5.2. Country Dynamics
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Regulatory Scenario

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
  • 9.4.1. Danaher
    • 9.4.1.1. Participant's Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Recent Developments/ Strategic Initiatives
  • 9.4.2. BD
    • 9.4.2.1. Participant's Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Recent Developments/ Strategic Initiatives
  • 9.4.3. Sysmex Corporation
    • 9.4.3.1. Participant's Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Recent Developments/ Strategic Initiatives
  • 9.4.4. Apogee Flow Systems Ltd.
    • 9.4.4.1. Participant's Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Recent Developments/ Strategic Initiatives
  • 9.4.5. Bio-Rad Laboratories, Inc.
    • 9.4.5.1. Participant's Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Recent Developments/ Strategic Initiatives
  • 9.4.6. Thermo Fisher Scientific, Inc.
    • 9.4.6.1. Participant's Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Recent Developments/ Strategic Initiatives
  • 9.4.7. Stratedigm, Inc.
    • 9.4.7.1. Participant's Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Recent Developments/ Strategic Initiatives
  • 9.4.8. Miltenyi Biotec
    • 9.4.8.1. Participant's Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Recent Developments/ Strategic Initiatives
  • 9.4.9. Cytek Biosciences
    • 9.4.9.1. Participant's Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Recent Developments/ Strategic Initiatives
  • 9.4.10. Sony Group Corporation (Sony Biotechnology Inc.)
    • 9.4.10.1. Participant's Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Recent Developments/ Strategic Initiatives